Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Mark Raffeld
Affiliation
Center for Cancer Research, National Cancer Institute
ORCID
Career Start Year
1981
Papers
410
H Index
96
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
38031352
Atypical Spitz tumor with SQSTM1::NTRK2 fusion: Report of a case with unique spindled cell features.
J Cutan Pathol
2024
38031352
Atypical Spitz tumor with SQSTM1::NTRK2 fusion: Report of a case with unique spindled cell features.
J Cutan Pathol
2024
37988030
Tissue Eosinophilia in B-cell Lymphoma: An Underrecognized Phenomenon.
Am J Surg Pathol
2024
37988030
Tissue Eosinophilia in B-cell Lymphoma: An Underrecognized Phenomenon.
Am J Surg Pathol
2024
36264007
A novel approach for characterization of KSHV-associated multicentric Castleman disease from effusions.
Br J Haematol
2023
35838483
Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in <i>ATG9A</i>.
Autophagy
2023
36264007
A novel approach for characterization of KSHV-associated multicentric Castleman disease from effusions.
Br J Haematol
2023
37966258
Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants.
Cancer Res Commun
2023
36461146
Follicle Center Lymphoma (FCL) of the Lower Female Genital Tract (LFGT): A Novel Variant of Primary Cutaneous Follicle Center Lymphoma (PCFCL).
Am J Surg Pathol
2023
37227187
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial.
Clin Cancer Res
2023
36598455
Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4 + Small/Medium T-Cell Lymphoproliferative Disorder : A Diagnostic Challenge Examined by Genomic Analysis.
Am J Surg Pathol
2023
37966258
Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 Participants.
Cancer Res Commun
2023
35838483
Autophagy-associated immune dysregulation and hyperplasia in a patient with compound heterozygous mutations in <i>ATG9A</i>.
Autophagy
2023
37227187
Targeting Replication Stress and Chemotherapy Resistance with a Combination of Sacituzumab Govitecan and Berzosertib: A Phase I Clinical Trial.
Clin Cancer Res
2023
36461146
Follicle Center Lymphoma (FCL) of the Lower Female Genital Tract (LFGT): A Novel Variant of Primary Cutaneous Follicle Center Lymphoma (PCFCL).
Am J Surg Pathol
2023
36598455
Overlapping Features of Primary Cutaneous Marginal Zone Lymphoproliferative Disorder and Primary Cutaneous CD4 + Small/Medium T-Cell Lymphoproliferative Disorder : A Diagnostic Challenge Examined by Genomic Analysis.
Am J Surg Pathol
2023
34555175
Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics.
Neuro Oncol
2022
35587280
Recurrent ACVR1 mutations in posterior fossa ependymoma.
Acta Neuropathol
2022
35650679
Clinicopathologic and Molecular Characterization of Epstein-Barr Virus-positive Plasmacytoma.
Am J Surg Pathol
2022
36201019
Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions.
Acta Neuropathol
2022
35982947
Case report: Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, associated with a germline mutation in <i>PMS2</i>.
Front Oncol
2022
35469800
Differential VHL Mutation Patterns in Bilateral Clear Cell RCC Distinguishes Between Independent Primary Tumors and Contralateral Metastatic Disease.
Urology
2022
34555175
Impact of the methylation classifier and ancillary methods on CNS tumor diagnostics.
Neuro Oncol
2022
34957617
An effective approach for BRAF V600E mutation analysis of routine thyroid fine needle aspirates.
Cytopathology
2022
35103816
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13.
Acta Neuropathol
2022
35587280
Recurrent ACVR1 mutations in posterior fossa ependymoma.
Acta Neuropathol
2022
35650679
Clinicopathologic and Molecular Characterization of Epstein-Barr Virus-positive Plasmacytoma.
Am J Surg Pathol
2022
35469800
Differential VHL Mutation Patterns in Bilateral Clear Cell RCC Distinguishes Between Independent Primary Tumors and Contralateral Metastatic Disease.
Urology
2022
36201019
Molecular and clinicopathologic characteristics of gliomas with EP300::BCOR fusions.
Acta Neuropathol
2022
35982947
Case report: Oligodendroglioma, IDH-mutant and 1p/19q-codeleted, associated with a germline mutation in <i>PMS2</i>.
Front Oncol
2022
35103816
High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13.
Acta Neuropathol
2022
34957617
An effective approach for BRAF V600E mutation analysis of routine thyroid fine needle aspirates.
Cytopathology
2022
32927122
UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma.
J Thorac Oncol
2021
35481284
CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development.
Oncoimmunology
2021
34283064
Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma.
Cancers (Basel)
2021
33527979
Clinicopathologic Features of Peripheral T-Cell Lymphoma in Sub-Saharan Africa.
Am J Clin Pathol
2021
33615670
Case report of adrenocortical carcinoma associated with double germline mutations in MSH2 and RET.
Am J Med Genet A
2021
34326811
Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study.
Front Endocrinol (Lausanne)
2021
32929178
The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy.
Mod Pathol
2021
32927122
UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma.
J Thorac Oncol
2021
34607348
Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant.
Blood Adv
2021
35481284
CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development.
Oncoimmunology
2021
33615670
Case report of adrenocortical carcinoma associated with double germline mutations in MSH2 and RET.
Am J Med Genet A
2021
33527979
Clinicopathologic Features of Peripheral T-Cell Lymphoma in Sub-Saharan Africa.
Am J Clin Pathol
2021
34607348
Long term follow-up of a phase II study of cladribine with concurrent rituximab with hairy cell leukemia variant.
Blood Adv
2021
34326811
Co-Occurrence of Familial Non-Medullary Thyroid Cancer (FNMTC) and Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Associated Tumors-A Cohort Study.
Front Endocrinol (Lausanne)
2021
34283064
Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma.
Cancers (Basel)
2021
32929178
The mutational landscape of histiocytic sarcoma associated with lymphoid malignancy.
Mod Pathol
2021
31439678
Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups.
Haematologica
2020
32132976
A Novel Risk Stratification System for Thyroid Nodules With Indeterminate Cytology-A Pilot Cohort Study.
Front Endocrinol (Lausanne)
2020
1 - 50 of 820
Column Actions
Search
Recommended Authors
Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year
2013
Number of shared co-authors
1
Xiaoqiong Wang
The University of Texas MD Anderson Cancer Center
Career Start Year
2011
Number of shared co-authors
0
David Wu
University of Washington
Career Start Year
2010
Number of shared co-authors
5
Alexandra E Kovach
Children's Hospital of Los Angeles
Career Start Year
2008
Number of shared co-authors
6
Jeremy C Wallentine
Intermountain Medical Center
Career Start Year
2007
Number of shared co-authors
0
Melissa H Cessna
Intermountain Medical Center
Career Start Year
2001
Number of shared co-authors
0
Trang Le
KTH - Royal Institute of Technology
Career Start Year
2000
Number of shared co-authors
0
Guang Fan
Oregon Health and Science University
Career Start Year
2000
Number of shared co-authors
3
Gyeongsin Park
Seoul St. Mary's Hospital, The Catholic University of Korea
Career Start Year
1999
Number of shared co-authors
0
Christopher J Howlett
Western University
Career Start Year
1999
Number of shared co-authors
0
Katia Basso
Institute for Cancer Genetics, Columbia University
Career Start Year
1999
Number of shared co-authors
0
Sze Fai Yip
Tuen Mun Hospital
Career Start Year
1999
Number of shared co-authors
0
David M Weinstock
Merck & Co.
Career Start Year
1998
Number of shared co-authors
3
Travis J Hollmann
Memorial Sloan Kettering Cancer Center
Career Start Year
1998
Number of shared co-authors
2
Eric Tse
School of Clinical Medicine, University of Hong Kong
Career Start Year
1997
Number of shared co-authors
6
Francisco Vega
The University of Texas MD Anderson Cancer Center
Career Start Year
1996
Number of shared co-authors
5
Jean Soulier
University of Paris
Career Start Year
1993
Number of shared co-authors
1
Seishi Ogawa
Kyoto University
Career Start Year
1993
Number of shared co-authors
5
Christopher D Gocke
Johns Hopkins University School of Medicine
Career Start Year
1992
Number of shared co-authors
10
Nicholas Sioutos
Center for Biomedical Informatics & Information Technology, National Cancer Institute
Career Start Year
1991
Number of shared co-authors
1
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year
1988
Number of shared co-authors
1
Kim E Nichols
St. Jude Children's Research Hospital
Career Start Year
1986
Number of shared co-authors
11
Laura Z Rassenti
University of California San Diego
Career Start Year
1985
Number of shared co-authors
7
Giorgio Inghirami
Meyer Cancer Center, Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year
1984
Number of shared co-authors
5
Sherrie L Perkins
University of Utah
Career Start Year
1982
Number of shared co-authors
7
David M Dorfman
Brigham and Women's Hospital and Harvard Medical School
Career Start Year
1982
Number of shared co-authors
1
Ulrich D??hrsen
University Hospital Essen, University of Duisburg-Essen
Career Start Year
1979
Number of shared co-authors
2
Riccardo Dalla-Favera
Institute for Cancer Genetics, Columbia University
Career Start Year
1978
Number of shared co-authors
5
Dennis B Cornfield
Lehigh Valley Hospital
Career Start Year
1977
Number of shared co-authors
4
Thomas J Kipps
University of California San Diego
Career Start Year
1977
Number of shared co-authors
8
row(s) 1 - 30 of 30
Collaborators
Elaine S Jaffe
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers
182
Stefania Pittaluga
National Cancer Institute, National Institutes of Health
Co-authored papers
105
Maryalice Stetler-Stevenson
National Cancer Institute, National Institutes of Health
Co-authored papers
36
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers
25
Jeffrey Cossman
Co-authored papers
17
Giuseppe Giaccone
Meyer Cancer Center
Co-authored papers
13
Martha Quezado
National Cancer Institute (NCI), National Institutes of Health (NIH)
Co-authored papers
12
Zied Abdullaev
Co-authored papers
11
Elias Campo
Institute for Biomedical Research August Pi I Sunyer
Co-authored papers
11
Steven A Rosenberg
University of Colorado School of Medicine
Co-authored papers
11
Armando C Filie
National Cancer Institute, National Institutes of Health
Co-authored papers
10
Markku Miettinen
National Cancer Institute
Co-authored papers
9
Robert J Kreitman
National Cancer Institute
Co-authored papers
9
Arun Rajan
Center for Cancer Research, National Cancer Institute
Co-authored papers
8
Evgeny Arons
National Cancer Institute
Co-authored papers
7
Kenneth Aldape
National Cancer Institute
Co-authored papers
7
Michael R Emmert-Buck
The Francis Crick Institute
Co-authored papers
7
Nicholas P Restifo
National Cancer Institute, National Institutes of Health (NIH)
Co-authored papers
6
Alexander O Vortmeyer
Indiana University School of Medicine
Co-authored papers
6
Emanuel F Petricoin
Center for Applied Proteomics and Molecular Medicine, George Mason University
Co-authored papers
6
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers
6
Yisong Wang
Lombardi Comprehensive Cancer Center, Georgetown University
Co-authored papers
6
Drew Pratt
Co-authored papers
6
Edward H Oldfield
National Institutes of Health
Co-authored papers
5
David J Liewehr
Center for Cancer Research
Co-authored papers
5
John R Wunderlich
National Cancer Institute
Co-authored papers
5
Olli Kallioniemi
Karolinska Institute
Co-authored papers
5
Lance A Liotta
Co-authored papers
5
Zhengping Zhuang
National Cancer Institute, National Institutes of Health
Co-authored papers
5
Amy D Klion
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers
5
1 - 30